| Molly Brown, | |
|
800 E Main St #310, Wytheville, VA 24382-2062 | |
| (276) 228-6200 | |
| Not Available |
| Full Name | Molly Brown |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 800 E Main St #310, Wytheville, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376081877 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Molly Brown, 800 E Main Street #310, Wytheville, VA 24382 Ph: (276) 228-6200 | Molly Brown, 800 E Main St #310, Wytheville, VA 24382-2062 Ph: (276) 228-6200 |
News Archive
Researchers at the Fisher Center for Alzheimer's Disease Research laboratory today published "Gamma-secretase Activating Protein is a Therapeutic Target for Alzheimer's Disease" in Nature online. Drs. Gen He (lead author) and Paul Greengard have discovered a protein that stimulates the production of beta-amyloid, and therefore represents a major new advance in Alzheimer's disease research.
At the joint conference of the American Society of Human Genetics/International Congress on Human Genetics in Montreal on October 12, GeneDx, one of the foremost genetics laboratories in the world and a subsidiary of Bio-Reference Laboratories, Inc., is announcing a first-of-its-kind test that will enable physicians and patients to more accurately identify the genetic cause of rare diseases.
​Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, and Jeffrey W. Olin, DO, FAHA, Professor of Cardiology and Director of the Vascular Medicine and Vascular Diagnostics Laboratory at the Icahn School of Medicine at Mount Sinai, received awards at the American Heart Association Scientific Sessions, November 12-16, 2016.
Eli Lilly and Company today announced positive top-line results of two additional Phase III AWARD trials for dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a once-weekly treatment for type 2 diabetes.
› Verified 1 days ago
Grayson Pate Mccarty, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 E Main St Ste 160, Wytheville, VA 24382 Phone: 276-228-6200 | |
Mrs. Brooke Little Hylton, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 770 W Ridge Rd, Wytheville, VA 24382 Phone: 276-223-3200 Fax: 276-223-0617 | |
Stacy Brown, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 E Main St Ste 200, Wytheville, VA 24382 Phone: 276-525-6043 | |
Kelly Miller Wyrick, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 E Main St, Wytheville, VA 24382 Phone: 276-228-6200 | |
H2 Health Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 E Main St Ste 160, Wytheville, VA 24382 Phone: 276-228-6200 Fax: 276-228-9175 | |
Patricia Paulette Clark, OCCUPATIONAL THERAPI Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 342 Virginia Avenue, Heartland Rehabilitation Services Of Virginia Inc, Wytheville, VA 24382 Phone: 276-228-6200 Fax: 276-228-9175 |